Biophan Receives Additional U.S. Nanotechnology Patent

Biophan Technologies, a developer of next-generation biomedical technology, has been issued Patent No. 6,864,418, "Nanomagnetically Shielded Substrate," by the U.S. Patent and Trademark Office.

The patent expands the patent coverage over nanomagnetic materials that are licensed from Nanoset to Biophan. This patent has applications in medical device technology being developed for commercial use by Biophan to protect patients having pacemakers and other similar implanted devices from potential harm due to magnetic resonance imaging (MRI).

The patent focuses on the nanoscale composition, structure and tuning of nanomagnetic shielding materials, and the effects these design properties have on the way the shield coating performs in the complex and powerful electromagnetic fields used in MRI. These specialized properties can be engineered to provide shielding for medical devices that are tuned to protect against these MRI-related electromagnetic fields.